4.7 Letter

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Journal

ANNALS OF ONCOLOGY
Volume 32, Issue 1, Pages 120-121

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2020.10.474

Keywords

-

Categories

Funding

  1. Forschungskredit University of Zurich [54171101]
  2. Swiss Cancer League [KFS-3115-02-2013]
  3. Cancer Research Institute
  4. Ludwig Institute for Cancer Research
  5. 'Hoch-spezialisierte Medizin Schwerpunkt Onkologie und Schwerpunkt Immunologie (HSM-2-Immunologie)' of the Canton Zurich, Switzerland

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available